Q4 2025

Filed Aug 29, 2025 · 10-K · 90 days after period end · 0001641172-25-026041

Q4 2025 · 10-K

derived · Computed from the longer spans the company filed.

Revenue

$749.00K

derived−33.0% vs Q4 2024

Net Income

-$1.54M

derivedN/M vs Q4 2024

EPS, diluted—

Same quarter

Metric	Q4 2025derived from reported figures	Q4 2024derived from reported figures	Q4 2023derived from reported figures	Q4 2022derived from reported figures
Revenue	$749.00K	$1.12M	$1.11M	$5.30M
Net Income	-$1.54M	-$1.42M	-$1.79M	-$1.76M

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Biomerica Inc · CIK 73290 · Engraved from SEC EDGAR